Approval · Notice of Compliance 396 · 2002
CYTOGAM: Notice of Compliance 396
Issued June 14, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 396
- Date
- June 14, 2002
- Company
- Medimmune Inc.Gaithersburg, Maryland, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New fractionation site
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYTOGAM | Not yet assigned | — |
Medicinal ingredients
- CYTOMEGALOVIRUS IMMUNOGLOBULIN (HUMAN) 50 MG per ML